Skip to contents
Research and development

Science-based development of our own products

We combine scientific knowledge, clinical practice, regulatory requirements, and the real needs of patients into solutions with measurable benefits

How we work

How GRANCREO products are developed

Development begins with an analysis of market and patient needs. We then prepare a specialised design of formula, conduct pre-manufacturing testing, manufacture the product through certified partners, and complete the registration process. Clinical data and real-world feedback are key components of this process.

Formula design with an emphasis on efficacy and tolerability
Manufacturing in accordance with international quality standards
Clinical real-world validation of efficacy
Go to timeline
Product development process
from laboratory design to clinical practice
13 months

average product development

Expert approach

development in cooperation with doctors and pharmacists

4 to 8 months

clinical trial and observational studies

GMP • ISO • IFS

certified manufacturing processes and quality control

Development process

Timeline from idea to market launch

The process is systematically managed from initial analysis up to clinical data. For international markets, we adapt both the formula and communication to local requirements.

Phase 1
approx. 3 months

Analysis of market and patient needs

We identify medical needs, competitors, and the practical expectations of doctors, pharmacists, and patients.

Phase 2
approx. 4 months

Design of formula and dosage

Together with experts, we design the composition and dosage form of the product with an emphasis on efficacy, stability, and tolerability.

Phase 3
approx. 2 months

Pre-manufacturing testing and stability

We validate product parameters prior to manufacturing to ensure that both technical and safety criteria are met.

Phase 4
3 to 6 months

Manufacturing by certified partners

Manufacturing is carried out in accordance with international standards, with regular inspections of both raw materials and the final product.

Phase 5
approx. 1 month

Registration and market launch

We prepare documentation, local approvals, and a communication framework for the streamlined launch of the product.

Phase 6
4 to 8 months

Clinical trial and observational studies

After launch, we monitor real-world efficacy and tolerability to further optimise the product for both patients and healthcare professionals.